Articolo su Rivista

Articolo su Rivista: [35046] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 6.061 a 6.080 di 35.046

Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: A phase II trial from an Italian cooperative group

2006-01-01 Benasso, M; Ponzanelli, A; Merlano, M; Numico, G; Ricci, I; Vigo, V; Grossi, F; Amadori, D; Cavallo, G; Capaccetti, B; Taveggia, P; Boni, L; Rosso, R

Randomized phase IIIb trial evaluating the continuation of bevacizumab beyond disease progression in patients with advanced non-squamous non-small-cell lung cancer after first-line treatment with bevacizumab plus platinum-based chemotherapy: treatment rationale and protocol dynamics of the AvaALL (MO22097) trial.

2011-01-01 Gridelli, C; Bennouna, J; de Castro, J; Dingemans, Am; Griesinger, F; Grossi, F; Rossi, A; Thatcher, N; Wong, Ek; Langer, C.

Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment

2021-01-01 Marozzi, M.; Parnigoni, A.; Negri, A.; Viola, M.; Vigetti, D.; Passi, A.; Karousou, E.; Rizzi, F.

Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: A review of the literature

2007-01-01 Grossi, F; Aita, M; Follador, A; Defferrari, C; Brianti, A; Sinaccio, G; Belvedere, O

Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)

2013-01-01 O'Brien, Me; Gaafar, Rm; Popat, S; Grossi, F; Price, A; Talbot, Dc; Cufer, T; Ottensmeier, C; Danson, S; Pallis, A; Hasan, B; Van Meerbeeck, Jp; Baas, P

Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer

2012-01-01 Genova, C; Rijavec, E; Barletta, G; Sini, C; Dal Bello, Mg; Truini, M; Murolo, C; Pronzato, P; Grossi, F

Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.

2008-01-01 Tiseo, M; Ardizzoni, A; Cafferata, Ma; Loprevite, M; Chiaramondia, M; Filiberti, R; Marroni, P; Grossi, F; Paganuzzi, M.

Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice?

2006-01-01 Tiseo, M; Franciosi, V; Grossi, F; Ardizzoni, A

Public R&D Subsidies: Collaborative versus Place-Based Programs for SMEs

2019-01-01 Pennacchio, Luca; Bellucci, Andrea; Zazzaro, Alberto

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer.

2012-01-01 Vergnenègre, A; Ray, Ja; Chouaid, C; Grossi, F; Bischoff, Hg; Heigener, Df; Walzer S,

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

2006-01-01 Ardizzoni, A; Cafferata, Ma; Tiseo, M; Filiberti, R; Marroni, P; Grossi, F; Paganuzzi, M

Rare shear-type fracture of the talar head in a thirteen-year-old child — Is this a transitional fracture: A case report and review of the literature

2021-01-01 Monestier, L.; Riva, G.; Faoro, L.; Surace, M. F.

Oral Vinorelbine Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-Line Treatment for Patients with Advanced non- Squamous non- Small Cell Lung Cancer: a Cost Minimization Analysis in Twelve European Countries

2015-01-01 Bucher, D; Grossi, F

Malformazioni dell’orecchio esterno: i peduncoli auricolari

2012-01-01 Salvatici, E.; Banderali, G.; Bresesti, I.; Scelsa, V.; Selmi, R.; Pipolo, C.; Felisati, G.

Gli effetti della distanza su alcune componenti della relazione creditizia. Evidenze empiriche

2011-01-01 Bellucci, Andrea; Favaretto, Ilario

A Detailed Description of the EC2M Project: Exploiting Ontologies for the Automatic and Manual Documents Classification in Industrial Enterprise Content Management Systems

2014-01-01 Briola, D; Amicone, A

Advances in treatment of mesothelioma

2016-01-01 Maggioni, C; Barletta, G; Rijavec, E; Biello, F; Gualco, E; Grossi, F

Information given to cancer patients on diagnosis, prognosis and treatment: the clinical oncologist's perspective

2004-01-01 Belvedere, O; Minisini, A; Ramello, M; Sobrero, A; Grossi, F

Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity

2010-01-01 Borcard, F; Baud, M; Bello, C; Dal Bello, G; Grossi, F; Pronzato, P; Cea, M; Nencioni, A; Vogel, P

Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview

2014-01-01 Genestreti, G; Grossi, F; Genova, C; Burgio, Ma; Bongiovanni, A; Gavelli, G; Bartolotti, M; Di Battista, M; Cavallo, G; Brandes, Aa

Titolo	Data di pubblicazione	Autore(i)
Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: A phase II trial from an Italian cooperative group	1-gen-2006	Benasso, M; Ponzanelli, A; Merlano, M; Numico, G; Ricci, I; Vigo, V; Grossi, F; Amadori, D; Cavallo, G; Capaccetti, B; Taveggia, P; Boni, L; Rosso, R
Randomized phase IIIb trial evaluating the continuation of bevacizumab beyond disease progression in patients with advanced non-squamous non-small-cell lung cancer after first-line treatment with bevacizumab plus platinum-based chemotherapy: treatment rationale and protocol dynamics of the AvaALL (MO22097) trial.	1-gen-2011	Gridelli, C; Bennouna, J; de Castro, J; Dingemans, Am; Griesinger, F; Grossi, F; Rossi, A; Thatcher, N; Wong, Ek; Langer, C.
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment	1-gen-2021	Marozzi, M.; Parnigoni, A.; Negri, A.; Viola, M.; Vigetti, D.; Passi, A.; Karousou, E.; Rizzi, F.
Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: A review of the literature	1-gen-2007	Grossi, F; Aita, M; Follador, A; Defferrari, C; Brianti, A; Sinaccio, G; Belvedere, O
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)	1-gen-2013	O'Brien, Me; Gaafar, Rm; Popat, S; Grossi, F; Price, A; Talbot, Dc; Cufer, T; Ottensmeier, C; Danson, S; Pallis, A; Hasan, B; Van Meerbeeck, Jp; Baas, P
Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer	1-gen-2012	Genova, C; Rijavec, E; Barletta, G; Sini, C; Dal Bello, Mg; Truini, M; Murolo, C; Pronzato, P; Grossi, F
Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.	1-gen-2008	Tiseo, M; Ardizzoni, A; Cafferata, Ma; Loprevite, M; Chiaramondia, M; Filiberti, R; Marroni, P; Grossi, F; Paganuzzi, M.
Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice?	1-gen-2006	Tiseo, M; Franciosi, V; Grossi, F; Ardizzoni, A
Public R&D Subsidies: Collaborative versus Place-Based Programs for SMEs	1-gen-2019	Pennacchio, Luca; Bellucci, Andrea; Zazzaro, Alberto
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer.	1-gen-2012	Vergnenègre, A; Ray, Ja; Chouaid, C; Grossi, F; Bischoff, Hg; Heigener, Df; Walzer S,
Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer	1-gen-2006	Ardizzoni, A; Cafferata, Ma; Tiseo, M; Filiberti, R; Marroni, P; Grossi, F; Paganuzzi, M
Rare shear-type fracture of the talar head in a thirteen-year-old child — Is this a transitional fracture: A case report and review of the literature	1-gen-2021	Monestier, L.; Riva, G.; Faoro, L.; Surace, M. F.
Oral Vinorelbine Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-Line Treatment for Patients with Advanced non- Squamous non- Small Cell Lung Cancer: a Cost Minimization Analysis in Twelve European Countries	1-gen-2015	Bucher, D; Grossi, F
Malformazioni dell’orecchio esterno: i peduncoli auricolari	1-gen-2012	Salvatici, E.; Banderali, G.; Bresesti, I.; Scelsa, V.; Selmi, R.; Pipolo, C.; Felisati, G.
Gli effetti della distanza su alcune componenti della relazione creditizia. Evidenze empiriche	1-gen-2011	Bellucci, Andrea; Favaretto, Ilario
A Detailed Description of the EC2M Project: Exploiting Ontologies for the Automatic and Manual Documents Classification in Industrial Enterprise Content Management Systems	1-gen-2014	Briola, D; Amicone, A
Advances in treatment of mesothelioma	1-gen-2016	Maggioni, C; Barletta, G; Rijavec, E; Biello, F; Gualco, E; Grossi, F
Information given to cancer patients on diagnosis, prognosis and treatment: the clinical oncologist's perspective	1-gen-2004	Belvedere, O; Minisini, A; Ramello, M; Sobrero, A; Grossi, F
Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity	1-gen-2010	Borcard, F; Baud, M; Bello, C; Dal Bello, G; Grossi, F; Pronzato, P; Cea, M; Nencioni, A; Vogel, P
Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview	1-gen-2014	Genestreti, G; Grossi, F; Genova, C; Burgio, Ma; Bongiovanni, A; Gavelli, G; Bartolotti, M; Di Battista, M; Cavallo, G; Brandes, Aa

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 6.061 a 6.080 di 35.046

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext24519
reserved5242
open5082
restricted107
partially open93
mixed2
embargoed1